Astrocytic Cebpd Regulates Pentraxin 3 Expression to Promote Fibrotic Scar Formation After Spinal Cord Injury

• Published in: Molecular neurobiology 2023-04, Vol.60 (4), p.2200-2208
• Main Authors: Wang, Shao-Ming, Hsu, Jung-Yu C, Ko, Chiung-Yuan, Wu, Hsiang-En, Hsiao, Yu-Wei, Wang, Ju-Ming
• Format: Article
• Language: English
• Subjects: Animals; Astrocytes; Astrocytes - metabolism; Biomedical and Life Sciences; Biomedicine; Cell Biology; Cicatrix - pathology; Fibroblasts; Fibrosis; Gliosis; Gliosis - pathology; Matrix Metalloproteinase 3 - metabolism; Mice; Neurobiology; Neurology; Neurosciences; NF-κB protein; Paralysis; Pentraxins; Peptides; Phosphorylation; Regeneration; Signal transduction; Spinal Cord - pathology; Spinal cord injuries; Spinal Cord Injuries - pathology
• ISSN: 0893-7648; 1559-1182
• DOI: 10.1007/s12035-023-03207-z

Astroglial-fibrotic scars resulted from spinal cord injury affect motor and sensory function, leading to paralysis. In particular, the fibrotic scar is a main barrier that disrupts neuronal regeneration after spinal cord injury. However, the association between astrocytes and fibrotic scar formation is not yet understood. We have previously demonstrated that the transcriptional factor Cebpd contributes to astrogliosis, which promotes glial scar formation after spinal cord injury. Herein, we show that fibrotic scar formation was decreased in the epicenter region in Cebpd −/− mice after contusive spinal cord injury and astrocytic Cebpd promoted fibroblast migration through secretion of Ptx3. Furthermore, the expression of Mmp3 was increased under recombinant protein Ptx3 treatment in fibroblasts by observing microarray data, resulting in fibroblast migration. In addition, regulation of Mmp3 occurs through the NFκB signaling pathway by using an irreversible inhibitor of IκBα phosphorylation in pretreated fibroblasts. Of note, we used the synthetic peptide RI37, which blocks fibroblast migration and decreases fibroblast Mmp3 expression in IL-1β-treated astrocyte conditioned media. Collectively, our data suggest that fibroblast migration can be affected by astrocytic Cebpd through the Ptx3/NFκB/Mmp3 axis pathway and that the RI37 peptide may act as a therapeutic medicine to inhibit fibrotic scar formation after spinal cord injury.